Yashad bhasma, also written as Yashada or Jasada bhasma, is the zinc-based bhasma of Rasa Shastra. It deserves careful study not because every traditional claim has already been translated into modern clinical proof, but because multiple analytical investigations have characterized it as a highly processed zinc preparation whose final chemistry, morphology, particle size, and dissolution behaviour differ from raw zinc metal and ordinary bulk zinc oxide.

The strongest modern case for Yashad bhasma is physicochemical: properly prepared samples have been examined with X-ray diffraction, electron microscopy, spectroscopy, elemental analysis, and particle-size methods. These analyses repeatedly show that traditional processing changes metallic zinc into zinc-containing particulate material, commonly reported as zinc oxide with nanoscale crystallite domains and larger agglomerates. This makes Yashad bhasma a serious subject for nanomedicine research, while still requiring strict quality control and practitioner supervision before clinical use.

What Yashad Bhasma Is: The Preparation Science

In Ayurveda, Yashada refers to zinc. Yashad bhasma is prepared through Rasa Shastra procedures that usually include shodhana purification, intermediate processing such as jarana and bhavana, and repeated marana incineration. The exact media and number of cycles vary by textual lineage and manufacturer, but modern pharmaceutico-analytical studies describe repeated processing with substances such as cow milk, herbal decoctions, Azadirachta indica leaf juice, and Aloe vera before or during incineration.

Shodhana: Zinc is processed to remove gross impurities and make it more suitable for further transformation. Reported methods include heating or liquefying zinc and repeatedly treating it with prescribed media such as cow milk or herbal liquids.

Jarana, bhavana, and marana: The purified zinc is reduced, triturated with herbal media, shaped or prepared for closed heating, and subjected to repeated incineration cycles. A modern ACS Omega investigation followed a 17-cycle incineration process and documented progressive transformation of the material across those cycles.

Analytical results should be read carefully. Some studies describe finished Jasada/Yashad bhasma as predominantly zinc oxide with a hexagonal wurtzite structure; a 2025 characterization reported zinc sulphide phases in its prepared sample. This variation reinforces a practical point: the clinical identity of a bhasma cannot be assumed from the name alone. Batch-specific testing is essential.

Particle Size, Zinc Form, and Bioavailability

The nanomedicine interest in Yashad bhasma comes from the way repeated classical processing changes size, crystal structure, and dissolution behaviour. One rat pharmacology and safety study reported traditionally prepared Jasada bhasma as 200-500 nm particles, predominantly zinc oxide with a hexagonal wurtzite crystal structure. Another physicochemical study found that the mean particle size fell from 2063 nm in raw zinc metal to 339.8 nm in Yashada bhasma by dynamic light scattering. A 2023 ACS Omega study documented crystallite-size reduction from 53.14 nm to 42.40 nm across incineration cycles, morphology reduction toward nanoscale features, and 10 nm particles in the finished product by high-resolution TEM.

The most useful interpretation is not that every Yashad bhasma particle is under 100 nm. Rather, high-quality preparations may contain nanoscale crystallites and nano-structured aggregates within a larger particulate matrix. That distinction matters because dynamic light scattering, SEM, TEM, SAXS, and XRD measure different aspects of size and structure.

Bioavailability claims are strongest when stated narrowly. In rats, oral Jasada bhasma increased serum zinc levels after dosing. In vitro, processed Jasada bhasma nanoparticles released bioavailable Zn²⁺ ions under acidic pH conditions and were taken up by intestinal Caco-2 cells without loss of cell viability at the tested concentrations. These findings support continued study of Yashad bhasma as a zinc-delivery system, but they do not establish that it is universally superior to zinc sulfate, zinc gluconate, or other conventional zinc supplements in humans.

Clinical Applications: Skin, Wounds, and Zinc Biology

Yashad bhasma is commonly discussed in relation to skin because zinc itself is important for barrier repair, keratinocyte function, immune regulation, antimicrobial defence, and wound healing. In Ayurveda, skin disorders are assessed through dosha, rakta, mamsa, agni, ama, chronicity, discharge, dryness, heat, itching, and the patient’s digestive and constitutional state; Yashad bhasma is not a stand-alone substitute for that assessment.

Acne vulgaris: Zinc has human clinical data for inflammatory acne, including a randomized comparison in which zinc gluconate improved inflammatory acne but was less effective than minocycline. For Yashad bhasma specifically, the better-supported acne-related work is in vitro: Yashada bhasma with Tankana was reported to inhibit Propionibacterium acnes, now commonly called Cutibacterium acnes, and reduce acne-related inflammatory responses in laboratory models. This supports the plausibility of topical or formulation research, not unsupervised oral use for acne.

Wound healing: Zinc participates in re-epithelialization, keratinocyte migration, metalloproteinase activity, collagen-related processes, and local immune defence. Yashad bhasma’s traditional association with ulcers and wounds fits this zinc biology, especially when used in properly designed topical formulations or as part of a practitioner-guided internal plan.

Inflammatory skin conditions: For conditions such as recurrent inflamed, dry, scaling, or slow-healing skin presentations, Yashad bhasma may be considered within an Ayurvedic framework when the practitioner identifies a suitable indication. It should not be presented as a proven disease-specific cure for psoriasis, eczema, or atopic dermatitis.

Immune Function Applications

Zinc is required for normal immune function, including the maturation and activity of immune cells. Zinc deficiency can impair immune responses, and adequate zinc status is relevant for skin repair, mucosal defence, and systemic resilience. Yashad bhasma may be considered as a classical zinc-containing preparation when an Ayurvedic practitioner identifies a suitable indication and when the product is quality-assured.

Its immune use should be framed as zinc support through a traditional herbo-mineral dosage form, not as a guaranteed prevention for respiratory infections. The patient’s age, diet, digestive strength, medication use, kidney status, pregnancy status, and existing zinc or copper supplementation all matter.

Safety Parameters and Quality Standards

The most important safety issue is not whether Yashad bhasma is “natural” or “mineral,” but whether it is correctly prepared, correctly tested, correctly prescribed, and correctly dosed. Rasa Shastra products require higher scrutiny than ordinary herbal teas or foods because they involve metals or minerals by design.

Use only products from licensed manufacturers that provide batch-level quality documentation. A useful certificate of analysis should include identity testing, elemental composition, limits for lead, cadmium, mercury, and arsenic, and relevant physicochemical parameters. Particle-size data can be helpful, but it should not replace heavy-metal testing, elemental assay, and pharmacopoeial quality checks.

Do not calculate safety from bhasma weight alone. A 125 mg dose of Yashad bhasma is not automatically equivalent to a fixed amount of absorbed elemental zinc, because the finished chemistry, zinc percentage, solubility, and bioavailability vary by preparation. Conversely, long-term high zinc intake from any source can interfere with copper absorption. Extended zinc therapy should be supervised by a qualified clinician who can decide whether copper status, blood counts, or other markers need monitoring.

Yashad bhasma should be avoided for self-medication in children, pregnancy, lactation, chronic kidney disease, known heavy-metal exposure, unexplained anemia, neurologic symptoms, or concurrent mineral supplementation unless a qualified Ayurvedic practitioner and healthcare provider are involved.

Where Yashad Bhasma Fits in Modern Ayurveda

Yashad bhasma is best understood as a classical zinc-based bhasma with a growing analytical and preclinical research profile. Its strongest modern support lies in material characterization, zinc-ion release, intestinal cell uptake models, animal pharmacology, and zinc’s established biological roles in immunity, skin repair, and wound healing. Its weakest area is condition-specific human clinical comparison against standard zinc supplements or standard medical treatments.

This makes Yashad bhasma neither a dismissible “ash” nor a casually interchangeable zinc pill. It is a specialized Rasa Shastra medicine whose promise depends on the same factors emphasized in classical Ayurveda: correct preparation, correct indication, correct vehicle, correct dose, and correct patient selection.

For broader mineral-medicine context, see our overview of shilajit research and fulvic acid. For skin-system context, see psoriasis and the Ayurvedic gut-skin axis. For immune-support context, see guduchi immunity research.

Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Consult a qualified Ayurvedic practitioner or healthcare provider before using Yashad bhasma, zinc supplements, or any herbo-mineral preparation.

References

1. Investigating the Role of Classical Ayurveda-Based Incineration Process on the Synthesis of Zinc Oxide Based Jasada Bhasma Nanoparticles and Zn(2+) Bioavailability (2023), PubMed Central
2. Anti-diabetic activity and safety assessment of Ayurvedic medicine, Jasada bhasma (zinc ash) in rats (2013), PubMed
3. Physico-chemical characterization of traditionally prepared Yashada bhasma (2020), PubMed
4. Characterization and potential novel applications of zinc-based traditional medicine, Yashad Bhasma (2025), PubMed
5. Yashada bhasma (Zinc calx) and Tankana (Borax) inhibit Propionibacterium acne and suppresses acne induced inflammation in vitro (2014)
6. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris (2001), PubMed
7. Rrpharmacology (rrpharmacology.ru)
8. NIH Office of Dietary Supplements
9. NIH Office of Dietary Supplements
10. Jamanetwork (jamanetwork.com)
11. Pib (pib.gov.in)
12. Pib (pib.gov.in)
13. Irjay (irjay.com)

Rasa Shastra is the Ayurvedic pharmaceutical discipline that includes the processing and therapeutic use of metals, minerals, gems, and mineral-derived materials. It remains one of the most debated areas of Ayurveda because raw or poorly manufactured metal-containing products can be harmful, while the classical tradition requires elaborate purification, repeated incineration, and quality testing before internal use.

Modern analytical chemistry has added a clearer view of what happens during bhasma preparation. X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), field-emission TEM, energy-dispersive spectroscopy, inductively coupled plasma atomic emission spectroscopy, and related tools have been applied to selected bhasmas. The picture that emerges is more precise than the common claim that every bhasma is simply a “nanomedicine”: some preparations contain nanoscale particles, some contain submicron or micrometre-scale agglomerates made of smaller crystallites, and many show chemical phases that are distinctly different from the raw starting material.

This article reviews the analytical evidence in that balanced sense: bhasma preparation can create finely divided, chemically transformed mineral preparations, but the results are substance-specific, batch-specific, and dependent on the completeness of processing and testing.

What Is a Bhasma? The Classical Process

A bhasma is a calcined ash or calx prepared through repeated pharmaceutical processing. The steps vary by substance and textual tradition, but the core logic is consistent: remove impurities, alter the physical and chemical nature of the material, combine it with selected media through trituration, and subject it to controlled heating cycles until it passes classical quality tests.

1. Shodhana: The raw metal or mineral is purified through procedures such as heating, quenching, washing, levigation, or treatment with media such as sour gruel, buttermilk, cow urine, oil, herbal decoctions, lime water, or other substance-specific liquids.
2. Jarana and allied processing: In some metallic preparations, an intermediate step is used to make the purified metal brittle, more reactive, and suitable for further incineration.
3. Bhavana: The processed material is triturated with herbal juices, decoctions, or other prescribed liquids. This step can reduce particle size, improve mixing, and add organic residues or surface-associated constituents.
4. Marana: The material is formed into small cakes or pellets, dried, sealed in earthen containers, and subjected to repeated puta or controlled heating cycles until the desired ash-like state is obtained.
5. Bhasma pariksha: The finished material is examined through classical tests such as rekhapurnata, varitara, nishchandratva, apunarbhava, and niruttha to judge fineness, lightness, loss of metallic luster, irreversibility, and suitability for therapeutic use.

The analytical question is not merely whether the particles become small, but whether the raw metal or mineral is transformed into a stable, reproducible, and pharmaceutically acceptable final material.

What Analytical Studies Have Actually Found

Different bhasmas do not all produce the same chemical form or particle-size range. Gold-based bhasmas may remain elemental gold at nanoscale dimensions, zinc and tin preparations may form oxides, iron preparations may form iron-oxide minerals, and mica-derived preparations may retain complex silicate and oxide phases. The following table summarizes verified analytical findings without assigning one universal particle size to all bhasmas.

The most reliable conclusion is that classical processing can substantially alter both particle structure and chemical form, but each bhasma requires its own analytical profile. A generic table assigning every bhasma to the same 20–100 nm range oversimplifies the actual literature.

Chemical Transformation: More Than Particle Size

Particle size is only one part of bhasma analysis. The chemical phase is equally important. XRD and related methods show that many metallic bhasmas are not simply powdered raw metals. Zinc preparations can become ZnO, tin preparations can become tin oxide, iron preparations can become magnetite or ferric oxide phases, and copper preparations can show copper oxide phases. Swarna Bhasma is a special case because verified analyses describe nanoscale elemental gold rather than a gold oxide.

This matters for safety and pharmacology because elemental metals, oxides, sulfides, silicate matrices, and nanoparticulate forms can behave very differently in the body. The classical tests of niruttha and apunarbhava address the same broad concern in traditional language: the finished bhasma should not behave like the original metal and should not easily return to a crude metallic state.

For Yashada Bhasma, a documented preparation showed incomplete transformation after an earlier heating stage, while the later prepared material was identified as ZnO and passed classical tests. That kind of stepwise transformation is exactly why both classical pariksha and modern instrumental testing are valuable.

Classical Bhasma Tests as Practical Quality Screens

The classical pariksha methods are practical bedside-style tests rather than substitutes for laboratory analysis. Rekhapurnata checks whether the powder is fine enough to enter the lines of the fingers. Varitara checks whether the powder can float on still water. Nishchandratva checks absence of metallic shine. Apunarbhava and niruttha examine whether the material remains stable and does not return to a crude metallic form under specified procedures.

These tests are meaningful because they assess fineness, lightness, lusterlessness, and irreversible processing. However, passing varitara alone does not prove that every particle is within the 1–100 nm nanotechnology range. Floating behavior can be influenced by particle size, aggregation, surface texture, wetting behavior, and bulk density. The strongest approach is to treat classical tests as necessary screening tools and pair them with XRD, SEM/TEM, ICP-MS or ICP-AES, and batch-level contaminant analysis.

Why Nanostructure Matters Biologically

In nanomedicine, particle size, surface charge, solubility, coating, aggregation, and protein binding influence absorption, cellular interaction, biodistribution, and clearance. Particles in the nanoscale or submicron range may interact with intestinal epithelial cells, mucus, immune cells, and M cells differently from coarse powders. This gives a plausible scientific reason to examine bhasmas with modern nanomaterial tools.

That does not mean a nanoscale bhasma automatically has predictable clinical effects. A 20 nm gold particle, a 300 nm ZnO particle, and a micrometre-scale agglomerate of iron-oxide nanocrystallites are different materials. Their behavior depends not only on size but also on dose, route of administration, solubility in gastric and intestinal fluids, surface chemistry, accompanying anupana, and the patient’s condition.

For Swarna Bhasma, in vitro and animal-level work provides a basis for continued investigation of gold-particle preparations. For Lauha, Yashada, Vanga, Tamra, and Abhraka preparations, the analytical value lies in showing how classical processing changes the material, not in assuming that all such products behave identically.

Safety Considerations: Where Caution Is Warranted

The analytical finding that some bhasmas are finely divided or nanoscale is a double-edged observation. It may help explain why classical processing was developed so carefully, but it also raises modern safety concerns. Finely divided particles can have higher surface area, different reactivity, and different tissue interactions than bulk materials. Metal-containing preparations therefore require careful sourcing, testing, dosing, and clinical supervision.

Reports of heavy-metal exposure from Ayurvedic products are real and should not be dismissed. Surveys of Ayurvedic medicines purchased in stores or online have found lead, mercury, or arsenic in a significant minority of products, and public-health reports have documented lead poisoning associated with Ayurvedic medications. These findings do not prove that every classically prepared bhasma is unsafe, but they do prove that product quality and supervision are essential.

Comparing Bhasmas to Modern Nanoformulations

There are meaningful parallels between some bhasmas and modern nanomaterials, but they should not be treated as identical. Zinc oxide is widely used in modern topical products such as sunscreens, and zinc oxide nanoparticles are studied for wound-related biomedical applications. Iron oxide nanoparticles, including ferumoxytol, are used in modern medicine as regulated injectable products. Gold nanoparticles are widely investigated as drug carriers, imaging agents, and cancer-therapy adjuncts.

The similarity is that particle size and surface properties matter in both traditional bhasma analysis and modern nanomedicine. The difference is that approved nanomedicines are manufactured under defined pharmaceutical standards, with controlled route of administration, dose, sterility, pharmacokinetics, warnings, and formal regulatory documentation. Bhasmas vary by raw material, processing method, number of heating cycles, media used for bhavana, manufacturer, and testing discipline.

For context on how other traditional preparations interact with biological systems at the molecular level, COX-2 Inhibition Explained examines how plant-derived compounds affect specific enzymatic pathways.

Practical Implications

For clinicians and patients, the practical message is neither blind rejection nor casual acceptance. Bhasmas are potent metal- or mineral-derived preparations that require the same seriousness as any other high-risk pharmaceutical material.

1. Use only tested products: A bhasma should come from a manufacturer able to document raw-material identity, classical processing, finished-product testing, and contaminant limits.
2. Ask for batch-level analysis: XRD or equivalent phase analysis, particle characterization, and heavy-metal contaminant testing are more meaningful than generic marketing language.
3. Respect classical dose and duration: Traditional bhasma doses are small and indication-specific. More is not better, and long-term use should not be casual.
4. Avoid self-prescription: Bhasmas should be used only under a qualified Ayurvedic physician trained in Rasa Shastra and aware of the patient’s medical history.
5. Coordinate with modern care: Patients should inform their healthcare provider about bhasma use, especially if taking medicines, managing kidney or liver disease, pregnant, breastfeeding, elderly, or using the preparation for a child.
6. Monitor when therapy is extended: Periodic liver function, kidney function, blood counts, and relevant toxic-metal testing may be prudent when bhasmas are used beyond a short course.

For those interested in the broader relationship between Ayurvedic formulation science and modern pharmacology, The Science of Anupana explores how carrier substances modify absorption and distribution.

Where the Evidence Stands

Bhasma analysis is one of the more useful meeting points between Ayurveda and modern pharmaceutical chemistry. It allows traditional preparations to be examined as materials: What phase is present? How large are the particles? Are they agglomerated? What elements are present? Is the raw metal transformed? Does the product pass both classical and instrumental quality checks?

The available analytical picture supports a qualified conclusion. Properly processed bhasmas can be chemically and physically distinct from their raw starting materials, and some contain nanoscale or nanostructured features. At the same time, the findings are not uniform across all bhasmas or all manufacturers. A gold bhasma, a zinc oxide bhasma, a tin oxide bhasma, an iron oxide bhasma, and a mica-derived bhasma are different materials and should be evaluated separately.

The most responsible position is continued scientific interest with strict quality control and clinical caution. Classical processing deserves careful study, but safety and efficacy must be judged preparation by preparation, batch by batch, and patient by patient.

Nothing in this article diagnoses, treats, cures, or prevents disease. Consult a qualified Ayurvedic practitioner and a licensed healthcare provider before starting herbs, minerals, supplements, detoxes, or therapeutic protocols, especially if pregnant, breastfeeding, giving to a child, managing a medical condition, or taking medication.

References

1. Bhasma : The ancient Indian nanomedicine (2014), PubMed Central
2. Omicsonline (omicsonline.org)
3. FDA
4. Link (link.springer.com)
5. Progenresearchlab (progenresearchlab.com)
6. Nanostructured gold in ancient Ayurvedic calcined drug ‘swarnabhasma’ (2021), PubMed
7. Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed Central
8. Physicochemical characterization of Suvarna Bhasma, its toxicity profiling in rat and behavioural assessment in zebrafish model (2020), PubMed
9. Arxiv (arxiv.org)
10. Ijpsonline (ijpsonline.com)
11. Ijam (ijam.co.in)
12. Library (library.ncl.res.in)
13. Preparation and characterization of a copper based Indian traditional drug: tamra bhasma (2005), PubMed
14. Physico-chemical characterization of traditionally prepared Yashada bhasma (2020), PubMed
15. Effect of calcination cycles on the preparation of tin oxide based traditional drug: studies on its formation and characterization (2006), PubMed
16. Ijam (ijam.co.in)
17. Nanoparticles of biotite mica as KrishnaVajraAbhraka Bhasma: synthesis and characterization (2021), PubMed Central
18. Library (library.ncl.res.in)
19. Characterization of biotite drugs used in traditional medicine (2020), PubMed Central
20. FDA
21. Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle (2022), PubMed Central
22. FDA
23. Gold nanoparticles as novel agents for cancer therapy (2012), PubMed Central
24. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction (2016), PubMed Central
25. Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties (2024), PubMed Central
26. Heavy metal content of ayurvedic herbal medicine products (2004), PubMed
27. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed
28. Jamanetwork (jamanetwork.com)
29. CDC
30. CDC
31. Mahayograj guggulu: Heavy metal estimation and safety studies (2010), PubMed Central
32. Clinical trial on different dose patterns of Shodhanartha Abhyantara Snehana (2013), PubMed
33. Phytochemical and analytical evaluation of Jyotishmati (Celastrus paniculatus Willd.) leaf extracts (2014), PubMed
34. Anxiolytic and nootropic activity of Vetiveria zizanioides roots in mice (2015), PubMed

Few topics in Ayurvedic medicine generate as much controversy as bhasma preparations. These calcined metal, mineral, and animal-origin preparations belong to the Rasa Shastra tradition and have a long clinical history, yet they also sit at the center of legitimate safety concerns about lead, mercury, arsenic, and other toxic elements in Ayurvedic products.

A careful reading is more useful than either blanket fear or blanket reassurance. Properly manufactured bhasma is not the same as accidental heavy-metal contamination in an herbal capsule, because its intended material, processing, particle size, and chemical form all matter. At the same time, laboratory testing has repeatedly found unsafe metals in some commercial Ayurvedic products, especially products bought from unverified sources. Safety depends on identity, classical processing, chemical speciation, batch testing, dose, duration, and medical supervision.

What Are Bhasma Preparations?

Bhasma means an ash-like calcined product. In Rasa Shastra pharmaceutics, a metal, mineral, shell, pearl, coral, or related material is processed through purification and incineration stages known broadly as shodhana and marana. The material may be triturated with herbal juices or decoctions, made into pellets, sealed in earthen containers, and repeatedly heated. The intended result is a fine, lusterless, stable preparation rather than crude metal powder.

Classical and pharmaceutic quality checks are used to judge whether incineration has reached the expected endpoint. Modern laboratories add elemental analysis and structural analysis to these traditional tests, because the same named bhasma can vary by raw material, heating method, number of calcination cycles, and manufacturer.

What Modern Analysis Adds

Modern testing separates several questions that are often mixed together: how much of an element is present, what chemical compound it is present as, what particle size and morphology it has, whether toxic impurities are present, and how much enters systemic circulation. ICP-MS, ICP-OES, ICP-AES, X-ray fluorescence, X-ray diffraction, scanning electron microscopy, transmission electron microscopy, and related methods each answer different parts of that safety question.

Total metal content alone is not enough to judge a genuine metal-based bhasma, because a gold, iron, copper, zinc, tin, lead, or mercury preparation will naturally contain the intended element. For safety, total elemental analysis must be read together with chemical form, solubility, particle size, dose, duration, patient factors, and batch purity. For herbal-only products, however, lead, mercury, arsenic, and cadmium are contaminants unless clearly declared and justified by the formulation.

Swarna Bhasma: Gold Content, Particle Form, and Absorption

Swarna Bhasma is one of the most discussed bhasma preparations because gold is a noble metal and the prescribed doses are small. Published characterization work has reported gold as the major phase in prepared samples, but the percentage and particle dimensions vary across preparations and methods.

In one pharmaceutical standardization study, Swarna Bhasma prepared through a traditional method passed selected bhasma tests such as varitaratva, rekhapurnatva, and expected color. The finished product contained 52.33% gold by ICP-OES, with lead and cadmium below detection limits in that batch, while arsenic and mercury were detected. The same report also recorded particle sizes in the 1–10 µm range by spot magnification, showing that not every finished product can be described simply as a uniform nanoparticle preparation.

A human pilot bioavailability assessment administered Swarnabhasma in three regimens and measured blood gold using ICP-MS. Gold was detected only in trace amounts after a single dose. This supports cautious dosing and supervision rather than casual long-term self-use, because trace absorption does not remove the need for product identity and contaminant testing.

Tamra Bhasma: Copper Form Is Central to Safety

Tamra Bhasma requires special caution because copper in inappropriate form or excessive dose can cause gastrointestinal and systemic toxicity. The Ayurvedic safety logic is that copper must be purified, repeatedly processed, and converted into a stable bhasma that passes classical endpoint tests.

A quality-control study of Tamra Bhasma prepared from copper wire applied shodhana, marana, and amritikarana, then evaluated the final product using classical tests and modern tools. The final product passed tests such as rekhapurnatva and varitaratva. XRD showed prominent peaks of cupric sulfide, SEM showed particles below 2 µm, particle-size distribution gave a volumetric mean diameter of 28.70 µm, and ICP-AES measured 56.42% copper with 23.06% sulfur. Arsenic, lead, and mercury were present only in traces in that sample, while cadmium and selenium were not detected.

These details are important because they correct an oversimplified claim often made in discussions of Tamra Bhasma: a named bhasma cannot be assumed to be only one oxide form, nor can safety be inferred from name alone. The batch must be tested.

Lauha Bhasma and Yashada Bhasma: Iron and Zinc Preparations

Lauha Bhasma and Yashada Bhasma are often discussed as lower-concern metal bhasma when properly manufactured, because iron and zinc are essential elements. That does not mean they are risk-free. Excess iron can accumulate in susceptible patients, and zinc preparations can vary in chemical form and impurities.

Work on Lauha Bhasma preparation has described the importance of sequential purification and calcination in changing raw iron into a more processed iron-based material. Structural investigation of medicinal-grade Lauha Bhasma reported conversion of metallic iron into iron-oxide mineral phases, with magnetite microparticles appearing as agglomerates of nanoparticles. Yashada Bhasma analyses have reported zinc oxide or zinc sulfide phases depending on the processing method, with ICP-based elemental profiling used to assess trace elements and heavy metals.

The JAMA Internet-Product Survey: What It Really Means

The widely cited JAMA survey of Ayurvedic medicines sold via the internet remains highly relevant for public safety. It purchased 230 products, received and analyzed 193, and found detectable lead, mercury, or arsenic in 20.7% of products. Rasa Shastra products had a higher prevalence of detectable metals than non-Rasa Shastra products, and all metal-containing products exceeded at least one standard for acceptable daily intake of toxic metals.

The survey should be read as a serious product-quality warning. It tested commercial products bought online, not carefully supervised individualized prescribing from a qualified practitioner. It also measured metal concentrations rather than clinical pharmacokinetics or chemical speciation. Still, its practical message is unavoidable: consumers cannot assume an Ayurvedic label, an online listing, or a stated GMP claim guarantees safety.

Total Metal, Chemical Form, and Bioavailability

Total metal content answers only one part of the safety question. Iron oxide, elemental iron, soluble iron salts, and iron bound in hemoglobin all contain iron but behave differently in the body. The same principle applies to copper, zinc, mercury, lead, and arsenic: chemical form and solubility matter.

Mercury illustrates the point clearly. Cinnabar and mercuric sulfide are poorly absorbed from the gastrointestinal tract compared with methylmercury and more soluble mercury salts. This distinction is chemically meaningful, but it is not a license for self-medication with mercury-containing preparations. Poor absorption does not mean zero absorption, and cumulative exposure, impurities, overheating, wrong processing, wrong dose, and vulnerable patients can still create risk.

Which Bhasma Carry Lower or Higher Concern?

A practical safety ranking should not claim that any bhasma is automatically safe. It should separate lower-concern mineral preparations from preparations that contain toxic metals or require especially narrow dosing discipline.

Lower Concern When Properly Manufactured

Some preparations are based mainly on calcium carbonate, silicate minerals, iron, or zinc. Their risk is usually driven by product purity, inappropriate indication, wrong dose, prolonged use, and patient susceptibility rather than by the inherent toxicity of lead or mercury.

• Shankha Bhasma: A conch-shell preparation, mainly calcium-rich, traditionally used for acid-peptic and digestive indications.
• Praval and Mukta preparations: Coral and pearl preparations are calcium-carbonate based but still require authenticity and contaminant checks.
• Abhraka Bhasma: A mica-based silicate preparation requiring careful processing and batch standardization.
• Lauha Bhasma: Iron-based; avoid unnecessary use in people with high ferritin, iron overload disorders, active infection concerns, or liver disease unless supervised.
• Yashada Bhasma: Zinc-based; avoid combining with other zinc supplements unless clinically indicated.

Moderate Concern Requiring Active Monitoring

These preparations can be clinically important in traditional practice, but the margin for error is smaller. Their use should be individualized, time-limited, and supported by batch-level testing.

• Tamra Bhasma: Copper-based; unsuitable for casual use, prolonged unsupervised courses, or patients with copper metabolism disorders.
• Vanga Bhasma: Tin-based; requires reliable manufacturing and practitioner supervision.
• Rajata Bhasma: Silver-based; chronic unnecessary exposure should be avoided.

High Concern and Specialist Use Only

Preparations containing lead, mercury, arsenic compounds, or closely related toxic mineral inputs require the highest safety threshold. They should never be treated as wellness supplements.

• Naga Bhasma: Lead-based; lead exposure is a genuine toxicological concern even when processed.
• Parada, Rasa Sindura, Makaradhwaja, and related mercury preparations: Require expert Rasa Shastra knowledge, legal compliance, contaminant testing, clear indication, limited duration, and monitoring.
• Formulations containing arsenic minerals: Require exceptional caution and should not be used without specialist oversight.

Quality Control Recommendations for Practitioners and Patients

The safest approach combines classical Rasa Shastra standards with modern laboratory quality control. Neither system should be used as a substitute for the other.

1. Use qualified supervision only: Bhasma preparations should be prescribed by a qualified Ayurvedic practitioner trained in Rasa Shastra, not self-selected from online listings.
2. Demand batch-level testing: A certificate of analysis should identify the batch and include elemental testing for lead, mercury, arsenic, cadmium, and relevant intended metals.
3. Prefer transparent manufacturers: The label should show batch number, manufacturing license details, ingredients, expiry, dose guidance, and safety warnings.
4. Verify identity and classical quality: Classical tests such as nishchandratva, rekhapurnatva, and varitaratva remain useful screening tools when performed by trained practitioners.
5. Avoid casual online purchase: Products sold without practitioner oversight, batch documentation, or transparent testing carry avoidable risk.
6. Use the lowest appropriate dose for the shortest appropriate duration: This principle is especially important for copper-, lead-, mercury-, arsenic-, and silver-containing preparations.
7. Use modern monitoring when risk is higher: Depending on the preparation, consider baseline and follow-up blood lead level, mercury level, liver function, kidney function, complete blood count, ferritin, copper status, or zinc status.
8. Disclose all medicines: Patients should tell both Ayurvedic and conventional healthcare providers about bhasma use, especially before surgery, pregnancy planning, or treatment for liver, kidney, neurological, gastrointestinal, or hematologic disease.

The Nanoparticle Dimension

Many bhasma discussions now use the word nanoparticle, but this needs precision. Some preparations contain nanoscale crystallites, some contain agglomerates of nanoparticles, and some measured batches show micrometre-scale particles. Particle size depends on raw material, grinding, calcination cycles, analytical method, and whether the measurement captures primary particles or agglomerates.

Nanoscale features may influence dissolution, surface area, tissue interaction, and dose behavior. They also add modern safety questions, because nanoscale materials can behave differently from bulk materials. For bhasma safety, particle-size claims should come from batch-specific SEM, TEM, XRD, DLS, or comparable analysis, not from the word bhasma alone.

A Balanced Safety Position

The most defensible position is neither to reject all bhasma as poison nor to accept all bhasma as safe. Properly prepared and properly prescribed bhasma is a distinct pharmaceutic category within Ayurveda. Poorly prepared, adulterated, mislabeled, or casually purchased products can cause real harm.

• Classical processing matters because incomplete incineration can leave unsuitable material.
• Modern batch testing matters because classical tests cannot quantify lead, mercury, arsenic, cadmium, or unintended contaminants.
• Chemical form matters because total elemental content does not equal absorbed toxic dose.
• Patient selection matters because children, pregnant or breastfeeding patients, and people with liver, kidney, neurological, or metabolic disorders may have much higher risk.
• Lead-, mercury-, and arsenic-containing preparations deserve the highest threshold of caution and should never be used as casual wellness supplements.

For a broader discussion of how carrier substances influence Ayurvedic administration, see The Science of Anupana.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Bhasma preparations should be used only under the supervision of a qualified Ayurvedic practitioner and, when appropriate, in coordination with a conventional healthcare provider. Do not self-medicate with mineral, metal, mercury, lead, arsenic, or herbo-mineral preparations. Seek medical care promptly if you develop abdominal pain, nausea, vomiting, constipation, metallic taste, fatigue, high blood pressure, tremor, neuropathy, confusion, anemia, kidney problems, or other symptoms suggestive of heavy-metal exposure. Children, pregnant or breastfeeding people, and patients with liver, kidney, neurological, or serious chronic illness should avoid bhasma unless a qualified specialist determines that use is appropriate and monitored.

References

1. Pdfs (pdfs.semanticscholar.org)
2. Pdfs (pdfs.semanticscholar.org)
3. Aamjournal (aamjournal.in)
4. Assessment of bioavailability of gold bhasma in human participants – A pilot study (2018), PubMed Central
5. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet (2008), PubMed
6. Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials? (2008), PubMed Central
7. FDA
8. Ayush (ayush.delhi.gov.in)
9. Pib (pib.gov.in)
10. Scientific validation of the different purification steps involved in the preparation of an Indian Ayurvedic medicine, Lauha bhasma (2012), PubMed
11. Structural investigation of Ayurveda Lauha (Iron) Bhasma (2023), PubMed Central
12. Mail (mail.greenpharmacy.info)
13. Ijpsonline (ijpsonline.com)

What follows is a clinically oriented review of ten key mineral and mineral-adjacent preparations associated with the Rasa Tarangini tradition. The focus is on verified classical indications, corrected safety context and cautious contemporary interpretation. This is not a guide to self-administration.

The Critical Safety Premise

Rasa Shastra medicines made from metals, minerals, gems and mineral exudates are not equivalent to the raw substances from which they begin. Classical pharmacy uses procedures such as Shodhana (purification), Bhavana (levigation with liquid media) and Marana (incineration/calcination) before a material is considered fit for internal administration. Finished Bhasma is also evaluated through traditional quality tests and, in responsible contemporary practice, through modern quality-control testing for identity, particle character and toxic contaminants.

This distinction is clinically important but not a licence for casual use. Inadequately processed, adulterated or contaminated Ayurvedic metal/mineral products have been associated with lead, mercury, arsenic and other heavy-metal exposure. Any Bhasma or herbo-mineral medicine should be used only when prescribed by a qualified Ayurvedic physician and sourced from a licensed manufacturer that provides appropriate quality testing.

1. Swarna Bhasma (Purified Gold Calx)

Classical profile: Rasa Tarangini describes properly prepared Swarna Bhasma as madhura, vrishya, hridya, netrya, medhya, rasayana, supportive of smriti, vayasthapana and useful in wasting conditions. The text also presents it as a high-value Rasayana drug used in small, physician-adjusted doses with suitable anupana.

Contemporary description: Characterised samples of Swarna Bhasma have shown gold-containing particles with nanoscale crystallites in some preparations, while other analyses describe a broader range of particle sizes depending on the manufacturing method. Laboratory work has also examined blood compatibility and macrophage-related immune activity, which aligns with the classical placement of Swarna among strengthening and Rasayana medicines, but it does not justify unsupervised use.

Clinical caution: Swarna Bhasma is among the most potent and expensive Bhasma preparations and should be reserved for clear indications, correct diagnosis and verified sourcing. It is inappropriate as a general wellness supplement without medical supervision, especially in children, pregnancy, kidney disease, liver disease or immunological disorders.

2. Rajata Bhasma (Silver Calx)

Classical profile: Rasa Tarangini describes Rajata after purification and processing as cooling, strengthening, medhya, supportive in shukrameha, prameha, old fevers, certain spleen/abdominal disorders, wasting conditions and selected nervous-system presentations. The text also warns that silver requires proper purification before internal use.

Contemporary description: Silver nanoparticles are well known in biomedical literature for broad antimicrobial material activity. That property should not be automatically transferred to every marketed Rajata Bhasma product, because particle size, chemical form, contaminants and processing quality vary by batch and manufacturer.

Clinical caution: Long-term or excessive silver exposure can cause argyria, an often irreversible blue-grey discoloration of skin and mucous membranes. Rajata Bhasma should therefore be used only in small classical doses, for a defined indication, and under professional supervision.

3. Tamra Bhasma (Copper Calx)

Classical profile: Rasa Tarangini is especially clear that unpurified copper is unsafe. It describes improper copper exposure as capable of causing nausea, vomiting, dizziness, heat, tissue depletion, diarrhoea and fainting. Properly prepared Tamra Bhasma is described as tikta, kashaya, madhura, ushna, lekhana, saraka, and useful in conditions involving yakrit, pliha, udara, pandu, kasa, shwasa, krimi, kushta, grahani and sthaulya.

Contemporary description: Physicochemical work on Tamra Bhasma has described nanocrystalline copper-containing material and in-vitro antibacterial activity in some prepared samples. This supports the importance of processing and standardisation, not the use of crude copper or untested products.

Clinical caution: Copper has a narrower safety margin than many other mineral preparations. People with copper-metabolism disorders, including Wilson disease, should avoid copper-containing preparations unless a specialist explicitly advises otherwise. Extended use requires clinical judgment and appropriate monitoring.

4. Loha Bhasma (Iron Calx)

Classical profile: Rasa Tarangini describes Loha Bhasma as tikta-kashaya, madhura vipaka, shita virya, lekhana, balya, vrishya, netrya and medhya. Its major clinical placement is in pandu, kamala, yakrit-related weakness, pliha disorders, meha, arsha, shwasa, kshaya and strength-depleting conditions. Classical combinations often pair Loha with substances such as Triphala, honey, ghee, Haritaki, Katuki or other disease-specific vehicles.

Contemporary description: Structural analysis of medicinal-grade Lauha/Loha Bhasma has identified iron-oxide phases such as magnetite, often present as agglomerates of nanoscale particles. This is chemically different from simply swallowing metallic iron filings and also different from ordinary ferrous sulphate tablets.

Clinical caution: Loha Bhasma should not be used blindly for fatigue. Anaemia has many causes, and iron-containing preparations are unsuitable in iron-overload states such as hereditary haemochromatosis, hemosiderosis and some haemolytic conditions. Diagnosis and monitoring are essential.

5. Abhraka Bhasma (Mica Calx)

Classical profile: Rasa Tarangini places Abhraka in the mica section and gives multiple processing methods involving repeated puta cycles. It describes properly prepared Abhraka Bhasma as snigdha, shishira, svadu, ayushya, keshya, varnya, ruchikara, dipana, balya, netrya, medhya, and useful in jwara, rajayakshma, kasa, shwasa, raktapitta, grahani, pandu, halimaka and meha.

Contemporary description: Characterisation of Abhraka Bhasma preparations has identified micro- and nanoscale mineral particles, with one analytical study describing a substantial fraction in the 50–500 nm range. The number of heating cycles, raw mica quality and processing media can materially change the finished product.

Clinical caution: Abhraka Bhasma should not be chosen by name alone. Batch quality, degree of processing, absence of gritty material and contaminant testing matter. Respiratory, wasting and Rasayana indications require professional assessment rather than self-selection.

6. Vanga Bhasma (Tin Calx)

Classical profile: Rasa Tarangini describes Vanga Bhasma as generally light, cooling, dry, medhya, tikta-kashaya with slight saltiness, ruchikara, kaphahara and useful in prameha, excessive urinary or reproductive discharges, shukra-related debility, pandu, chronic cough/respiratory difficulty and certain krimi presentations. The text also notes that processing media can influence whether the finished preparation behaves more cooling or heating.

Contemporary description: Vanga Bhasma remains primarily a classical genitourinary and prameha-oriented preparation rather than a general diabetes supplement. Its use depends heavily on roga, dosha, dushya, urinary findings, reproductive tissue assessment and the selected anupana.

Clinical caution: Tin-containing preparations require the same caution as other metallic Bhasma. They should not be used for urinary symptoms without ruling out infection, kidney disease, diabetes complications, prostate disease or other biomedical causes.

7. Mandura Bhasma (Processed Iron Rust / Iron Oxide Calx)

Classical profile: Rasa Tarangini describes Mandura Bhasma after purification and incineration as vrishya, shishira, ruchira, dipana, pitta-shamana and raktavardhaka. It is classically used in pandu, kamala, shotha, shosha, halimaka and pliha-related disorders, often with Triphala, Punarnava, Katuki, Vidanga or other disease-specific herbs.

Contemporary description: Mandura is an iron-based preparation, traditionally distinguished from Loha Bhasma by its raw material and processing context. Its classical placement is especially relevant where anaemia-like presentations are associated with liver, spleen, oedema or digestive impairment patterns.

Clinical caution: Mandura Bhasma should be avoided in iron-overload conditions and should not replace diagnostic work-up for anaemia, jaundice, oedema or liver disease. Laboratory assessment is important when symptoms suggest systemic disease.

8. Parada Preparations (Mercury-Based Medicines)

Parada is central to Rasa Shastra literature, but it is also the most safety-sensitive category. Raw mercury is toxic and is not treated as an ordinary supplement. Classical processing includes purification and combinations such as mercury-sulphur triturations in the wider Rasa Shastra tradition; preparations such as Kajjali and Rasasindura require specialised pharmacy, identity testing and expert use.

My clinical position is conservative: Parada-based preparations should be considered only in exceptional, clearly justified cases under a highly qualified physician, with lawful sourcing and laboratory testing. In many jurisdictions, products containing mercury or excessive heavy metals may be detained, restricted or considered unsafe. Plant-based and non-mercurial options are preferable for most routine conditions.

9. Shilajit / Shilajatu (Mineral Pitch; Semi-Mineral Rasayana)

Shilajit is not a Bhasma; it is a mineral exudate included in the Rasa Shastra pharmaceutic world. Rasa Tarangini discusses its purification, tests for purified material, properties and use. The text describes purified Shilajatu as predominantly tikta, katu vipaka, especially mutrala, yogavahi and rasayana, with uses in mutrakrichra, mutraghata, ashmari, prameha, sthaulya, heart-related indications and reproductive weakness depending on formulation and vehicle.

Contemporary description: Purified Shilajit contains humic substances including fulvic acid and has been evaluated in controlled human work. A randomised, double-blind, placebo-controlled trial using purified Shilajit at 250 mg twice daily for 90 days reported increases in total testosterone, free testosterone and DHEAS in healthy male volunteers. Other work has examined fatigue-related performance and mitochondrial models, but product purity remains central.

Clinical caution: Unpurified or adulterated Shilajit may contain heavy metals, mineral grit or other contaminants. Only purified, tested products should be used, and people with kidney disease, gout tendency, high uric acid, iron overload, pregnancy, lactation or complex chronic illness should consult a qualified practitioner before use.

10. Praval Bhasma (Coral Calx)

Classical profile: Rasa Tarangini describes Praval/Vidruma after proper preparation as madhura, light, cooling, dipana, pachana, beneficial for eye disorders, tridosha-shamana with special effect on Kapha-Vata, balya, useful in kshaya-kasa, raktapitta, excess sweating and night sweating. It is also traditionally associated with Pitta-calming, cooling and calcium-supportive contexts.

Contemporary description: Analytical work on Praval Bhasma has shown transformation of coral-derived calcium carbonate material during processing, with finished products differing from raw coral in particle size and chemical character. It should therefore be understood as a processed calcium-rich Ayurvedic preparation rather than ordinary coral powder.

Clinical caution: Praval Bhasma is generally considered gentler than many metallic Bhasma, but it still requires quality assurance. People with kidney stones, chronic kidney disease, hypercalcaemia, sarcoidosis, parathyroid disorders or those taking calcium/vitamin D therapeutically should avoid casual use.

Comparative Safety Reference

The following table summarises the practical safety position for these preparations. “Contemporary support” refers to available analytical, experimental or limited human data; it does not mean a preparation is appropriate without diagnosis, sourcing control and physician oversight.

This article is for educational purposes only. Mineral, metal, gem and herbo-mineral preparations should be used only under the guidance of a qualified Ayurvedic practitioner or healthcare provider. Self-administration of heavy metal-based preparations is dangerous. Pregnant women, nursing mothers, children, older adults, and individuals with kidney disease, liver disease, metabolic disorders or unexplained symptoms should avoid Bhasma preparations unless under direct specialist care.

References

1. Archive (archive.org)
2. Bhasma : The ancient Indian nanomedicine (2014), PubMed Central
3. NCCIH
4. FDA
5. Archive (archive.org)
6. Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed Central
7. Nature (nature.com)
8. Swarna Bhasma Induces Antigen-Presenting Abilities of Macrophages and Helps Antigen Experienced CD4(+) T Cells to Acquire Th1 Phenotypes Against Leishmania donovani Antigens (2024), PubMed Central
9. Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects (2014), PubMed Central
10. Physicochemical characterization and antibacterial activity of Rajata Bhasma and silver nanoparticle (2016), PubMed Central
11. NCBI
12. Study on physical properties of Ayurvedic nanocrystalline Tamra Bhasma by employing modern scientific tools (2019), PubMed Central
13. Arxiv (arxiv.org)
14. NCBI
15. Europepmc (europepmc.org)
16. Physicochemical characterization of an Iron based Indian traditional medicine: Mandura Bhasma (2011), PubMed Central
17. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers (2016), PubMed
18. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels (2019), PubMed Central
19. In-house preparation and characterization of an Ayurvedic bhasma: Praval bhasma (2014), PubMed

The comparison is not that Bhasma is an exosome. It is more precise to say that both fields force the same pharmacological question: how can a small, structured particle survive biological environments, interact with cellular barriers, and produce effects that are different from the unprocessed raw material? Rasa Shastra approached this question through Shodhana, Bhavana, Marana, and Bhasma Pariksha. Modern nanomedicine approaches it through XRD, SEM, TEM, DLS, zeta potential, spectroscopy, and biological assays.

What Is Bhasma? The Classical Process Revisited

Bhasma is a calcined preparation made from metals, minerals, gems, shells, or related substances after classical purification and incineration procedures. In Rasa Shastra, the raw substance is not used casually; it is repeatedly purified, triturated with prescribed liquids or herbal media, formed into pellets when required, and heated through controlled cycles until the material becomes a fine, stable ash suitable for medicinal use under expert supervision.

Classical quality tests remain central to the identity of Bhasma. Varitara assesses lightness by whether the fine powder can float on still water. Rekhapurnatva assesses fineness by whether the powder enters the lines of the fingers. Nishchandratva assesses absence of metallic lustre. Apunarbhava and Niruttha assess whether the material resists reversion to its original metallic state. These tests do not replace modern analysis, but they show that particle fineness, stability, and complete transformation were already built into classical quality control.

Where the Nanoparticle Discussion Fits

Modern analytical work on Bhasma has found that some preparations contain nanoscale crystallites, nano-sized particles, or nano-sized substructures within larger aggregates. This does not mean every commercial Bhasma is automatically a therapeutic nanoparticle. Particle size can vary widely between batches and manufacturers, and the same Bhasma name can refer to products with different elemental composition, morphology, and biological behaviour.

This is why the most useful modern framing is not “ancient Ayurveda already made perfect nanoparticles,” but rather: Rasa Shastra created repeatable pharmaceutical processes that can transform metals and minerals into fine, chemically altered, biologically distinctive preparations. Nanoscience gives us tools to describe those transformations more clearly.

The Exosome Parallel: Size, Structure, and Biological Transport

Exosomes are small extracellular vesicles, commonly described in the range of about 30–150 nm, secreted by cells and carrying nucleic acids, proteins, lipids, and metabolites. Plant-derived exosome-like nanoparticles from edible plants such as ginger, grape, grapefruit, carrot, lemon, and others are being explored as natural carriers because their lipid membrane can protect cargo and help cellular uptake.

Ginger-derived nanoparticles are a useful comparison because they have been characterised as natural, lipid-rich carriers containing plant bioactives and small RNAs, with uptake by intestinal epithelial cells and macrophages in preclinical models. Their biological behaviour is linked not only to size, but also to membrane composition and surface interaction with cells.

Bhasma preparations differ completely in origin and structure: they are inorganic or herbo-mineral calcined materials, not lipid vesicles. Still, the comparison highlights an important principle: the biological behaviour of a medicine can depend on the whole particle system, including size, surface chemistry, aggregation, charge, and processing history, not merely on the name of the element.

Swarna Bhasma: The Most Studied Preparation

Swarna Bhasma, the classical calcined gold preparation, has received the most modern attention because gold is easier to track with contemporary analytical tools. Reports on Swarna Bhasma have described gold crystallites in the nanometre range in some preparations, while other studies have found larger aggregates and substantial manufacturer-to-manufacturer variation.

One blood compatibility study described Swarna Bhasma preparations with gold crystallite size around 28–35 nm and reported no blood cell aggregation, no protein adsorption, negligible complement and platelet activation, and non-cytotoxic behaviour in the tested in vitro systems. Another cell-entry study found that incinerated Swarna Bhasma particles differed from chemically synthesised gold nanoparticles; individual crystallites were around 60 nm, but the material formed much larger irregular aggregates and entered cells through endocytosis-related pathways.

The practical lesson is important: Swarna Bhasma cannot be understood as simple gold powder. Its behaviour depends on how the gold is processed, what secondary elements or organic residues remain, whether the particles are nanoscale or aggregated, and whether the final product has passed both classical and modern quality checks.

Abhraka Bhasma: Mica Transformed Through Processing

Abhraka Bhasma is prepared from mica. Classical Ayurveda places it among important Rasayana-oriented mineral preparations, especially in formulations concerned with strength, respiratory resilience, tissue nourishment, and chronic debility. Its traditional prestige is tied to repeated purification and incineration cycles, including higher-cycle preparations such as Shataputi or Sahasraputi Abhraka in classical practice.

Modern analytical reports on Abhraka Bhasma describe major mineral elements such as iron, silicon, aluminium, potassium, magnesium, calcium, and related oxide or silicate phases depending on the source and process. Some FEG-SEM reports describe heterogeneous aggregates with particles in the nanometre range, while other analyses report broader micro-to-nano distributions. This supports the classical idea that mica is not simply powdered and consumed; it is transformed into a different processed material.

It is more accurate to call Abhraka Bhasma a complex mica-derived herbo-mineral preparation than an “iron-free but iron-equivalent” medicine. Its classical use is not reducible to iron replacement, and its modern profile is not yet defined by a single confirmed pathway.

Tamra Bhasma and Copper-Based Nanocrystalline Materials

Tamra Bhasma is the classical calcined copper preparation. It is among the Bhasmas where safety discipline is especially important, because improperly processed copper preparations can be harmful. Classical Rasa Shastra therefore gives strong importance to purification, incineration, and testing before use.

Analytical work on Tamra Bhasma has characterised it as a copper-based preparation containing copper compounds such as copper oxides and related phases, with nanocrystalline features reported in some samples. Preliminary antimicrobial testing has reported activity against bacteria, but this should be read as early laboratory work rather than a reason for self-medication.

The modern antimicrobial interest in copper nanoparticles gives Tamra Bhasma a plausible research context, but the Ayurvedic medicine cannot be equated casually with chemically synthesised copper nanoparticles. Processing media, final chemical form, dose, particle size, and purity all matter.

Lauha Bhasma: Iron After Classical Transformation

Lauha Bhasma is the classical calcined iron preparation and is traditionally used in conditions corresponding to Pandu and iron-deficiency states under Ayurvedic diagnosis. Modern structural work has reported that metallic iron can transform through processing into iron oxide phases such as magnetite or related iron oxides, often appearing as agglomerates of nano-sized particles.

This supports a key Rasa Shastra principle: metals are not intended to be used in crude metallic form. The point of Bhasmikarana is transformation into a form that is finer, chemically altered, and suitable for carefully supervised therapeutic use.

Vanga Bhasma and the Limits of Mechanistic Claims

Vanga Bhasma, the calcined tin preparation, is classically used in selected genitourinary, metabolic, and reproductive contexts depending on the formulation and diagnosis. Analytical reports describe porous or granular particles and tin-containing phases in some preparations, but the modern pharmacological mechanism is not yet settled.

Because of that uncertainty, it is better to discuss Vanga Bhasma as an important classical preparation needing stronger analytical and clinical standardisation, rather than assigning it a speculative mechanism such as “tin-ion glycaemic modulation.”

The Blood-Brain Barrier Question

The blood-brain barrier is one of the major obstacles in drug delivery because it restricts entry of many small-molecule and large-molecule therapeutics into the brain. Nanomedicine research therefore pays close attention to particle size, surface charge, surface ligands, shape, and transcytosis pathways.

Some gold nanoparticle systems can be engineered for cellular uptake and barrier transport, and Swarna Bhasma has been studied for cellular entry. However, a direct clinical claim that Swarna Bhasma crosses the human blood-brain barrier or treats neurodegenerative disease through such a pathway would go beyond the established evidence. The safer, more accurate position is that Swarna Bhasma is a meaningful candidate for further mechanistic work because its classical use, gold content, particle behaviour, and modern gold-nanoparticle literature overlap in interesting ways.

Quality Control: The Critical Gap

Quality control is the point where classical Ayurveda and modern safety science must meet. A Bhasma may be beautifully described in a text, but the commercial product in a bottle is only as reliable as its raw material selection, purification, incineration, batch control, contamination testing, and final verification.

Modern studies of commercial Ayurvedic preparations have documented serious risks from lead, mercury, arsenic, and other metals in some products. Even within a single category such as Suvarna Bhasma, manufacturer-to-manufacturer differences in size, shape, composition, gold percentage, and bioaccumulation profile have been reported. Therefore, a responsible Bhasma recommendation requires a qualified Ayurvedic physician, a reputable manufacturer, GMP-level production, and analytical documentation for identity, purity, and safety.

Current Status and Research Needs

References and Further Reading

• Pal D, Sahu CK, Haldar A. Bhasma: The ancient Indian nanomedicine. Journal of Advanced Pharmaceutical Technology & Research. 2014.
• Paul W, Sharma CP. Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug. International Journal of Ayurveda Research. 2011.
• Beaudet D et al. Comparative study on cellular entry of incinerated ancient gold particles (Swarna Bhasma) and chemically synthesized gold particles. Scientific Reports. 2017.
• Biswas S et al. Physicochemical Variation in Nanogold-Based Ayurved Medicine Suvarna Bhasma Produced by Various Manufacturers Lead to Different In Vivo Bioaccumulation Profiles. Journal of Evidence-Based Integrative Medicine. 2021.
• Wadekar MP et al. Preparation and characterization of a copper based Indian traditional drug: Tamra bhasma. Journal of Pharmaceutical and Biomedical Analysis. 2005.
• Singh RK et al. Study on physical properties of Ayurvedic nanocrystalline Tamra Bhasma by employing modern scientific tools. Journal of Ayurveda and Integrative Medicine. 2019.
• Tiwari MK et al. Structural investigation of Ayurveda Lauha (Iron) Bhasma. Scientific Reports. 2023.
• Zhang M et al. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016.
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020.
• Hersh AM et al. Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology. International Journal of Molecular Sciences. 2022.

Safety disclaimer: Bhasma preparations, especially those containing metals such as gold, copper, iron, mercury, arsenic, or lead-containing ingredients in classical formulations, must only be used under the supervision of a qualified Ayurvedic physician and appropriate healthcare provider. Do not self-medicate with Bhasma or buy unverified products. This article is educational and does not diagnose, treat, prescribe, or recommend any specific product.

References

1. Bhasma : The ancient Indian nanomedicine (2014), PubMed Central
2. Ayurvedic Pharmacopoeia of India
3. Ayurvedic Pharmacopoeia of India
4. The biology, function, and biomedical applications of exosomes (2020), PubMed Central
5. Frontiersin (frontiersin.org)
6. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer (2016), PubMed
7. Pubs (pubs.acs.org)
8. Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed
9. Nature (nature.com)
10. SAGE Journals
11. Sciencedirect (sciencedirect.com)
12. Nanoparticles of biotite mica as KrishnaVajraAbhraka Bhasma: synthesis and characterization (2021), PubMed
13. Globalresearchonline (globalresearchonline.net)
14. Link (link.springer.com)
15. Library (library.ncl.res.in)
16. Study on physical properties of Ayurvedic nanocrystalline Tamra Bhasma by employing modern scientific tools (2019), PubMed Central
17. Dovepress (dovepress.com)
18. Structural investigation of Ayurveda Lauha (Iron) Bhasma (2023), PubMed Central
19. The blood-brain barrier: bottleneck in brain drug development (2005), PubMed Central
20. Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology (2022), PubMed Central
21. Sciencedirect (sciencedirect.com)
22. Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation (2017), PubMed Central
23. Jamanetwork (jamanetwork.com)
24. Journals (journals.plos.org)

What Is Bhasma? The Classical Pharmaceutical Framework

Bhasma is a fine calcined preparation made from specified metals, minerals, shells or other substances through formula-specific procedures described in Rasa Shastra literature and official Ayurvedic formularies. There is no universal recipe; the sequence, liquids, auxiliary substances, heat pattern and endpoint tests depend on the material and cited method.

1. Shodhana: preliminary processing that may involve heating and quenching, boiling, washing, grinding or treatment with prescribed liquids. Calling it removal of all “toxins” is too broad; it is material-specific purification and pharmaceutical pretreatment.
2. Bhavana: wet grinding or levigation with a specified juice, decoction or other liquid. It mixes ingredients, reduces coarse particles and prepares the mass for further processing.
3. Marana and Putapaka: repeated calcination according to the chosen method, often after pellets are enclosed in an earthen sharava-samputa. Modern studies may use a muffle furnace to reproduce a temperature profile. Depending on ingredients and atmosphere, the product may contain elemental metal, oxides, sulfides or mixed phases; the process is not uniformly a reduction reaction.
4. Amritikarana, where prescribed: some Tamra or Lauha methods include an additional finishing process. It is not mandatory for every bhasma, and evidence does not support calling it a universal organic coating or proven tissue-targeting step.

Classical endpoint examinations include nishchandratva (absence of visible metallic lustre), rekhapurnatva (fineness sufficient to enter finger lines), varitaratva (floating on still water in the prescribed test) and, where relevant, apunarbhava, which examines resistance to reversion toward the original metal. These process checks do not replace modern identity, composition, contamination, particle-distribution and toxicology testing.

What Microscopy and Diffraction Actually Show

Published measurements differ because studies examine different products and techniques. XRD crystallite size, TEM primary-particle size, SEM aggregate size and DLS hydrodynamic diameter are not equivalent. A powder can contain nanoscale crystallites while behaving as micron-scale aggregates in liquid.

The defensible conclusion is that bhasma processing can produce complex micro- and nanostructured materials. It is inaccurate to assign one fixed particle size to each named bhasma. Batch variation is a major research and quality-control issue.

Particle Size, Absorption and Bioavailability

Smaller particles can have greater surface area, but absorption depends on aggregation, dissolution, chemical species, protein binding, surface charge, dose, food, vehicle and intestinal physiology. General nanoparticle transport mechanisms cannot be automatically assigned to a bhasma without product-specific experiments.

A small 2018 human pilot study measured trace gold in blood after single sublingual or oral Swarna Bhasma doses and reported different concentration-time patterns with different routes and accompanying media. It did not establish long-term pharmacokinetics, tissue distribution, clinical benefit or safety in disease. In a 2017 cell-culture study, smaller incinerated-gold particles appeared to enter cells through clathrin-dependent endocytosis and larger aggregates through macropinocytosis; oral intestinal passage and organism-level effects remained unresolved.

Lauha Bhasma is traditionally used in iron-containing Ayurvedic formulations, and modern work has characterized iron-oxide phases, but comparative clinical bioavailability and gastrointestinal tolerability require proper human trials.

Herbal Processing and Surface Chemistry

Plant juices, decoctions, oils, milk products and other media can participate in grinding, complexation, oxidation, sulfide formation and transfer of trace constituents. Analytical studies have detected carbon and multiple elements in some samples. This supports research on process-derived surface chemistry.

Terms such as “functionalization,” “zeta-potential control” and “organ targeting” should be used only when measured for the exact preparation. No reliable human evidence shows that a processing liquid directs bhasma particles selectively to the heart, kidney, brain or another organ. Classical indications and modern nanoparticle-targeting mechanisms are different categories of evidence.

Specific Preparations: Current Evidence

Each preparation must be judged as a distinct pharmaceutical material. Traditional indications can guide research, but they do not substitute for verified trials, standardized composition or contemporary diagnosis.

Swarna Bhasma

Swarna Bhasma is a calcined gold preparation used in later Rasa Shastra and Ayurvedic pharmaceutical practice. The 2011 in-vitro study found negligible hemolysis, aggregation, platelet activation and cytotoxicity for its tested batches; the 2017 study found no toxicity in two cultured human cell lines under its conditions. These results are assay- and product-specific.

A randomized study of Swarna Bhasma, honey and ghee in healthy infants reported no significant between-group advantage in IgG over honey and ghee alone during the study period. It is not evidence that Swarna preparations function as vaccines or prevent infection. Pediatric use requires specialist oversight and reliable product quality.

Lauha Bhasma

Lauha Bhasma is an iron-based preparation produced by methods that may include shodhana, Triphala processing, calcination and amritikarana. Structural studies describe iron-oxide phases rather than one universally fixed compound. A 2016 rat study found no major toxicity at therapeutic-equivalent and five-times levels, but biochemical and histopathological alterations appeared at the highest repeated dose. Animal toxicology neither determines an individual dose nor proves superiority to standard oral iron.

Pravala Pishti

Pravala Pishti is a cold-processed coral preparation, not a bhasma produced by repeated incineration. It is made through fine grinding and levigation according to the selected formulary. It should not replace clinically indicated calcium or osteoporosis treatment.

The Safety Question

Safety cannot be inferred from the words “classical,” “purified,” “nano” or “GMP.” Case reports and surveys have documented lead, mercury or arsenic exposure from some Ayurvedic products, including severe liver injury and systemic toxicity. Conversely, controlled animal studies of particular, characterized bhasmas sometimes report acceptable findings at specified doses and harm at higher doses. Both realities must be acknowledged.

Traditional tests help monitor manufacture, while modern evaluation should include authenticated raw materials, validated process records, chemical speciation, assay of intended ingredients, limits for unintended contaminants, microbial quality and batch-specific certificates of analysis. India’s Drugs Rules place Ayurvedic, Siddha and Unani manufacturing under Schedule T GMP requirements intended to ensure authentic raw materials, prescribed processes, quality control and acceptable finished-product quality. GMP is important, but it does not guarantee clinical efficacy or zero risk.

Disclaimer: Never self-prescribe a bhasma or use an unlabelled metallic preparation. Use only a legally manufactured, batch-tested product prescribed by a qualified Ayurvedic physician experienced in Rasa Shastra, and tell your healthcare provider about every medicine and supplement you take. Extra caution and medical review are essential in pregnancy, childhood, kidney or liver disease, anemia of uncertain cause, and when medicines may affect renal, hepatic or blood function. Suspected adverse effects require prompt medical assessment and, when appropriate, blood metal testing.

Where Research Should Go Next

Research should establish reproducible manufacturing protocols, distinguish primary particles from aggregates, identify chemical species and surface constituents, measure dissolution and bioaccessibility, and compare batches from multiple manufacturers. Pharmacokinetic studies must track absorption, distribution and elimination rather than relying on one early blood measurement.

Clinical studies should use authenticated products, adequate controls, prespecified outcomes, transparent adverse-event reporting and independent replication. Until then, microscopy shows that classical processing can create complex materials; it does not prove rejuvenation, cognitive enhancement, organ targeting or superior bioavailability. Rasa Shastra is represented more accurately when analytical findings, classical doctrine and clinical claims remain clearly separated.

References

1. Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug (2011), PubMed
2. Nanogoldpharmaceutics (2007)
3. Comparative study on cellular entry of incinerated ancient gold particles (Swarna Bhasma) and chemically synthesized gold particles (2017)
4. Nanostructured gold in ancient Ayurvedic calcined drug ‘swarnabhasma’ (2021)
5. Characterization of Rajath Bhasma and Evaluation of Its Toxicity in Zebrafish Embryos and Its Antimicrobial Activity (2020), PubMed
6. Standard manufacturing procedure of Tamra Bhasma (2012)
7. Assessment of bioavailability of gold bhasma in human participants – A pilot study (2018), PubMed
8. Immunomodulatory activity of Swarna Prashana (oral administration of gold as electuary) in infants – A randomized controlled clinical trial (2019), PubMed Central
9. Toxicity study of Lauha Bhasma (calcined iron) in albino rats (2016), PubMed
10. Ayurveda metallic-mineral ‘Bhasma’-associated severe liver injury (2018), PubMed Central
11. Toxic metals in ayurvedic preparations from a public health lead poisoning cluster investigation (2017), PubMed Central
12. CDSCO (India)

Nothing in this article diagnoses or treats a medical condition. Use it as educational information and consult a qualified Ayurvedic practitioner or physician before starting herbs, supplements, detoxes, or therapeutic protocols, especially if pregnant, managing a condition, or taking medication.